AI in Pharma: Transforming Drug Discovery and Strategic Management with MYC-Modulating Compounds and BET Protein Inhibitors

Abstract

The landscape of pharmaceutical R&D is being reshaped by the synergistic integration of Artificial Intelligence (AI) and groundbreaking drug discoveries, mainly focusing on MYC-modulating compounds and BET protein inhibitors. This Patent Highlight delves into this convergence, illustrating a transformative shift in the pharmaceutical industry’s approach to drug development, strategic management, and treating various diseases, from cancer to inflammatory and fibrotic disorders.